A missense SCN3A [MIM:182391] SNV (p.Leu209Pro/c.626 T > C) in patient 45 was selected due to SCN3A association to epilepsy [49] (a phenotype presented by our patient), and the predicted deleterious effect of the variant, and was Sanger verified as de novo. This evidence concerns the gene SCN3A and epilepsy.